(2015). Neoantigens in cancer immunotherapy. Science 348, 69–74 . 6.Gubin, M.M., Artyomov, M.N., Mardis, E.R., and Schreiber, R.D. (2015). Tumor neoantigens: building a framework for personalized cancer immu-notherapy. J. Clin. Invest. 125, 3413–3421 . Cell Reports Medicine 1, 100141, November 17, 2020 7Reportll OPEN ACCESS 7.Ott, P.A., Hu-Lieskovan, S., Chmielowski, B., Govindan, R., Naing, A., Bhardwaj, N., Margolin, K., Awad, M.M., Hellmann, M.D., Lin, J.J., et al.(2020). A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer,or Bladder Cancer. Cell 183, 347–362 .